查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1792308

高內涵篩選市場報告（按產品、應用、最終用戶（製藥和生物技術公司、學術和政府機構、合約研究組織）和地區）2025 年至 2033 年

High Content Screening Market Report by Product, Application, End-User (Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations ), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球高內涵篩選市場規模達14億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到27億美元，2025-2033年期間的複合年成長率（CAGR）為7.13%。由於採用整合成像技術的應用，藥物研發應用的快速發展、藥物研究投資的不斷增加、對兼顧時間和成本的篩選方法的需求不斷成長，以及實驗室自動化系統的建立，這些因素共同推動了該市場顯著成長。

高內涵篩選市場分析：

  • 主要市場促進因素：高內涵篩選市場的成長主要得益於藥物研發需求的不斷成長、高通量生產的成像技術的進步，以及製藥和生物技術研究的大量投資。此外，對快速且有效率的篩選技術的需求，有助於識別和理解活性候選藥物，也為市場成長提供了動力。
  • 主要市場趨勢：市場趨勢包括使用資料分析的人工智慧和機器學習演算法的快速數位化、結合產生更多生理相關結果的 3D 細胞模型以及針對各種細胞模型的多範式分析的開發。
  • 地理趨勢：由於製藥和生物技術行業的快速發展、對研發的持續投資、以及與市場主要參與者和學術研究機構相關的先進醫療保健基礎設施，北美佔據了市場主導地位。
  • 競爭格局：該行業的一些主要市場參與者包括 Becton、Dickinson and Company、Bio-Rad Laboratories Inc.、Biotek Instruments Inc.、Danaher Corporation、GE Healthcare、Merck Millipore、Perkinelmer Inc.、Tecan Group Ltd.、Thermo Fisher Scientific、Yokogawa Electric Corporation 等。
  • 挑戰與機會：市場面臨許多挑戰，例如設備與試劑成本高昂，資料分析與標準複雜等。另一方面，高內涵篩選市場在開發新型創新成像技術或拓展其應用範圍（超越藥物研發）以及促進學術界和產業界合作研究以促進研發方面擁有巨大的機會。

高內涵篩選市場趨勢：

藥物研發需求不斷成長：

市場驅動力主要源自於對快速有效的藥物研發方法日益成長的需求。例如，美國國立衛生研究院 (NIH) 報告稱，預計到 2025 年，全球醫藥市場規模將幾乎加倍，達到 1.5 兆美元，這迫切需要先進的篩選技術。而高通量定序 (HCS) 則能夠同時分析多項參數，更早辨識潛在的候選藥物，從而縮短藥物研發時間。因此，製藥機構不得不信賴高通量定序 (HCS)，這不僅擴大了研究市場規模，也改善了藥物研發流程。

成像技術的持續進步：

公司不斷開發影像技術，以幫助提供更準確、更詳細和更專業的診斷工具，從而為高內涵篩選市場創造了積極的前景。例如，美國國家科學基金會 (NSF) 的報告顯示年成長率為 6.2%，這意味著越來越多的實驗室正在採用先進的成像模式操作，用於細胞分析的高內涵篩選。研究人員現在可以透過超解析度顯微鏡、共聚焦成像和活細胞成像設備即時製作細胞結構和運作的高品質影像。此類技術創新將在未來升級高內涵篩選系統，使其具有更高的分析精度和更詳細的結果，從而使識別細胞過程和對刺激的反應的工作變得更加先進和徹底。因此，結合最新成像技術的更清潔、更有效率的高內涵篩選系統的供應正在增加，這是市場發展的原因。

生技研究投資不斷增加

由於全球生技投資的不斷增加，高內涵篩選市場收入正在顯著成長。根據生物技術創新組織 (BIO) 的數據，2020 年全球生物技術研發支出超過 2,100 億美元，這表明在推動科學知識和開發新治療方案方面投入了大量資金。高內涵篩選在生物技術研究中佔據核心地位，因為它可以加速探討細胞功能和分子間相互作用的過程。生技公司和研究機構利用新的發現標靶進行藥物開發，評估化合物的療效和毒性，並闡明疾病機制，這些都是推動高內涵篩選市場需求成長的一些因素。因此，這種趨勢將推動市場成長，並推動高內涵篩選技術的進一步研究。

高內涵篩選市場細分：

按產品分類：

  • 儀器
    • 細胞成像和分析系統
    • 流式細胞儀
  • 耗材
    • 試劑和檢測試劑盒
    • 微孔板
    • 其他
  • 軟體
  • 服務
  • 配件

儀器佔大部分市場佔有率

儀器憑藉其精準高效的細胞分析，引領藥物研發和科研，在市場中佔據主導地位。例如，美國國立衛生研究院 (NIH) 預測，到 2025 年，全球科學研究設備和儀器的採購額將超過 530 億美元。如此龐大的投資也使得生物醫學研究領域對高內涵篩選儀器等尖端技術設備的需求日益成長。然而，大型製藥和生技公司已推出篩選平台技術，加速藥物研發進程，將推動高內涵篩選儀器的快速發展。因此，儀器製造商正將注意力轉向研發更先進的工具，以提供更佳的成像、自動化和資料分析功能，從而滿足那些始終追求新事物的科學家的需求。

按應用分類：

  • 目標識別與驗證
  • 初步篩選與二次篩選
  • 毒性研究
  • 化合物分析
  • 其他

初篩和復篩在業界佔比最大

由於加速藥物研發過程的緊迫性日益增強，初步篩選和二次篩選佔據了市場主導地位。根據美國國立衛生研究院 (NIH) 的資料，全球製藥業正在加速成長，預計到 2024 年銷售額將達到 1.2 兆美元。這為投資用於初步篩選的高內涵篩選技術提供了優勢，因為評估大量化合物庫以快速識別潛在候選藥物的能力已實現自動化和系統化。之後，基於細胞的檢測方法對於在二次篩選步驟中追蹤命中化合物、表徵其功效、安全性和作用機制至關重要。這加速了初級和二次高內涵篩選解決方案的採用。

按最終用戶分類：

  • 製藥和生物技術公司
  • 學術和政府機構
  • 合約研究組織（CRO）

製藥和生物技術公司佔據領先的細分市場

製藥和生物技術公司的發展動力源於加速藥物發現或開發的基本需求。根據美國國立衛生研究院 (NIH) 的數據，預計到 2025 年，全球製藥業的規模將超過 1.5 兆美元。如此龐大的市場機會吸引各公司投資先進的篩選技術，以快速篩選候選藥物。此外，高內涵篩選技術使製藥和生技公司能夠進行深入的細胞分析，從而評估候選藥物的有效性和副作用。透過使用高內涵篩選方法，這些公司可以基本上實現研究工作流程的自動化，從而縮短開發時間，更快地將新型療法推向市場。此外，影像技術和資料分析演算法的進步增強了高內涵篩選平台的威力，使其能夠發現未知的生命行為和疾病機制。因此，製藥和生技公司在高內涵篩選技術開發方面的投入不斷增加，從而促進了創新並改善了患者的治療效果。

按地區分類：

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

北美引領市場，佔據最大的高內容篩選市場佔有率

該報告還對所有主要區域市場進行了全面分析，包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告指出，北美是高內容篩選最大的區域市場。

由於政府向生物醫藥產業提供巨額撥款，北美佔據了生物醫藥市場主導地位。例如，美國國立衛生研究院（NIH）報告稱，美國政府每年在生物醫學研究預算中投入高達300億美元。這筆巨額投資刺激了創新，從而促進了更先進篩選技術的應用，推動了市場發展。此外，該地區擁有完善的醫療基礎設施、一群領先的研究機構以及高素質的勞動力，這些都為該地區在高內涵篩選市場中贏得了更高的聲譽。因此，北美在製藥和生物領域研發設備方面始終處於領先地位。

本報告回答的關鍵問題

  • 高內涵篩選市場有多大
  • 高內涵篩選市場未來前景如何
  • 推動高內涵篩選市場的關鍵因素有哪些
  • 哪個地區佔據最大的高內涵篩選市場佔有率
  • 全球高內涵篩選市場領先的公司有哪些

本報告回答的關鍵問題

  • 高內涵篩選市場有多大？高內涵篩選市場未來前景如何？
  • 推動高內涵篩選市場的關鍵因素有哪些？
  • 哪個地區佔最大的高內涵篩選市場佔有率？
  • 全球高內涵篩選市場領先的公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球高內涵篩選市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 儀器
    • 主要類型
      • 細胞成像和分析系統
      • 流式細胞儀
  • 耗材
    • 主要類型
      • 試劑和檢測試劑盒
      • 微孔板
      • 其他
  • 軟體
  • 服務
  • 配件

第7章：市場區隔：依應用

  • 目標識別與驗證
  • 初步篩選與二次篩選
  • 毒性研究
  • 化合物分析
  • 其他

第8章：市場區隔：按最終用戶

  • 製藥和生物技術公司
  • 學術和政府機構
  • 合約研究組織（CRO）

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格指標

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories Inc.
    • Biotek Instruments Inc.
    • Danaher Corporation
    • GE Healthcare
    • Merck Millipore
    • Perkinelmer Inc.
    • Tecan Group Ltd.
    • Thermo Fisher Scientific
    • Yokogawa Electric Corporation
Product Code: SR112025A1988

The global high content screening market size reached USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.7 Billion by 2033, exhibiting a growth rate (CAGR) of 7.13% during 2025-2033. The market is experiencing significant growth driven by rapid advancements in drug discovery applications through the use of integrated imaging technologies, heightening investments in pharmaceutical research, escalating demand for a screening method while minimizing time and cost, and the establishment of automated system in laboratories.

High Content Screening Market Analysis:

  • Major Market Drivers: The high content screening market growth is driven largely by the growing demand from drug discovery and development, progress in imaging technologies featuring high-throughput production, and large investments allocation to pharmaceuticals and biotechnology studies. Besides, the demand for expeditious and productive screening techniques, aiding the identification and understanding of active drug candidates, also adds fuel to the market growth.
  • Key Market Trends: The market trends include the rapid digitization of AI and machine learning algorithms that use data analysis, incorporating 3D cell models that produce more physiologically relevant results, and the development of multiparadigm assays for various cellular models.
  • Geographical Trends: North America dominate the market due to rapid development in the pharmaceutical and biotechnology industries, ongoing investments in research and development, advanced healthcare infrastructure which connects to the presence of market key players and academic research institutions.
  • Competitive Landscape: Some of the major market players in the industry include Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Biotek Instruments Inc., Danaher Corporation, GE Healthcare, Merck Millipore, Perkinelmer Inc., Tecan Group Ltd., Thermo Fisher Scientific, Yokogawa Electric Corporation, among many others.
  • Challenges and Opportunities: The market faces challenges such as the high cost of equipment and reagents, the complexity of data analysis and standards. On the other hand, high content screening market opportunities are enormous in terms of developing new innovative imaging technologies or broadening their range of applications beyond drug discovery and making collaborative studies between academia and industry easier for research and development.

High Content Screening Market Trends:

Increasing Demand for Drug Discovery:

The market is primarily driven by the increasing need for fast and effective drug discovery approaches. For instance, NIH reports that the global pharmaceutical market is anticipated to almost double and stand at 1.5 trillion dollars in 2025 thus urging for advanced screening technologies. HCS in turn enables the analyses of many parameters at the same time and the earlier identification of potential drug candidates, hence allowing shorter time to develop them. As a result, pharmaceutical organizations are forced to put their trust in HCSs which consequently makes the research market size larger and improves the discovery process of drugs.

Ongoing Advancements in Imaging Technologies:

The imaging technologies are continuously developed by companies, that help to provide more accurate, detailed, and specialized diagnostic tools, creating a positive high content screening market outlook. For instance, the National Science Foundation (NSF) report shows the annual growth of 6.2%, which means more and more laboratories are adopting the operatories of advanced imaging modalities for application in high content screening of cellular analysis. Researchers can now make high-quality images of the structures and workings of cells in real time via super-resolution microscopy, confocal imaging, and live-cell imaging facilities. Such technical innovations upgrade the high content screening systems with better analytical precision and more detailed results in the future, thus the work of identifying cellular processes and response to stimuli becomes more advanced and thorough. Hence, the supply of cleaner and more efficient high content screening systems, incorporating the latest imaging technics is rising which is responsible for the market development.

Rising Investments in Biotechnology Research

The high content screening market revenue is experiencing significant growth due to rising investments in biotechnology around the world. As per Biotechnology Innovation Organization (BIO), global spending on biotechnological R&D exceeded $210 billion in 2020 showing the investments made in advancing scientific knowledge as well as development of new therapeutic options. High content screening takes a central position in biotechnology research by speeding up the investigating process of wondering what the cells do and the interactions among the molecules. Biotech firms and research institutions utilizing new discovery targets for drug development, as well as assessing compound efficacy and toxicity, and elucidating disease mechanisms are some of the factors driving an increased high content screening market demand. As a result, this tendency will lead to market growth and further research on high content screening techniques will be done.

High Content Screening Market Segmentation:

Breakup by Product:

  • Instruments
    • Cell Imaging and Analysis Systems
    • Flow Cytometers
  • Consumables
    • Reagents & Assay Kits
    • Microplates
    • Others
  • Software
  • Services
  • Accessories

Instruments accounts for the majority of the market share

Instruments dominate the market by assuring a precise and effective cellular analysis that leads to discovery of drugs and research. For instance, NIH projections forecast that the figures for worldwide purchases of the research equipment and instrumentation will pass $53 billion mark by 2025. This high magnitude investment thus accounts to the increasing demand for up-to-date technology equipment in biomedical research with high content screening instruments. However, major pharmaceutical and biotechnology firms have introduced screening platforms technologies in which drug discovery processes are accelerated that will lead to huge growth of high content screening instruments. As a result, those engaged in the manufacture of instruments are shifting their attention towards creating more modern tools that offer better imaging, automation, and data analysis features to satisfy the demand of scientists who are always looking for something new.

Breakup by Application:

  • Target Identification and Validation
  • Primary Screening and Secondary Screening
  • Toxicity Studies
  • Compound Profiling
  • Others

Primary screening and secondary screening hold the largest share of the industry

Primary screening and secondary screening dominate the market due to the rising urgency of accelerating the drug discovery process. According to data from NIH, the global pharmaceutical industry is experiencing an accelerated growth and is expected to reach an estimate of $1,200 billion in sales in 2024. This is a leverage to invest in high content screening technologies for primary screening, as the ability to evaluate large amounts of compound libraries to identify potential drug candidates quickly becomes automated and systematic. Afterward, cell-based assays are indispensable for following up on hit compounds in the secondary screening step, characterizing their efficacy, safety, and mechanism of action. This accelerates primary and secondary high content screening solutions adoption.

Breakup by End-User:

  • Pharmaceutical and Biotechnology Companies
  • Academic and Government Institutes
  • Contract Research Organizations (CROs)

Pharmaceutical and biotechnology companies represent the leading market segment

Pharmaceutical and biotechnology firms are driven by the basic necessity to speed up drug discovery or development in the field of market. As per the National Institutes of Health (NIH), the global drugs industry is anticipated to go beyond 1.5 trillion dollars by the year 2025. This abundant market chance therefore entices firms to invest in the state-of-the-art screening technologies to screen drug candidates swiftly. Moreover, high-content screening allows drug and biotechnology companies to perform in-depth cellular assays, thus enabling the evaluation of drug candidates' effectiveness and side-effect profiles. With the use of high content screening methods, these companies can essentially automate their research workflow and therefore shorten development timelines to bring novel treatments to the market faster. Furthermore, progress in imaging technology and data analysis algorithms adds to the power of high content screening platforms to the discovery of unsuspected life behaviors and disease mechanisms. Thus, investments of pharmaceutical and biotechnology companies in the development of high content screening run high leading to innovation and improvement of patient outcome.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest high content screening market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for high content screening.

North America dominates the market due to the provision of massive government grant to biomedical industry. For instance, the National Institutes of Health or NIH reported that the US government covers up to $30 billion in its yearly budget for biomedical research. This sizeable incurred investment, however, stimulates innovation, therefore enhancing the use of more advanced screening technologies resulting in the market development. Further, the area enjoys well-established medicine infrastructure, a cluster of leading research institutes and a labor force with a high level of competence which provide additional prestige to the region in the high content screening market. As result North America stays at the forefront of the equipment used in the pharmaceutical and biological sectors' research and development.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the high content screening industry include Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Biotek Instruments Inc., Danaher Corporation, GE Healthcare, Merck Millipore, Perkinelmer Inc., Tecan Group Ltd., Thermo Fisher Scientific and Yokogawa Electric Corporation.
  • The high content screening market companies are investing in the research and development (R&D) of the product to upgrade the product and broaden the market. Thermo Fisher Scientific, PerkinElmer, and GE Healthcare, amongst others, leading the trend in imaging technologies for high-content screening. For instance, Thermo Fisher Scientific spent around 1.1 billion dollars in 2020 on R&D activities. These investments aim to develop new imaging technologies, automation solutions and software platforms that are capable of driving the growing market and meeting the ever-searching demand for advanced cellular analysis and drug discovery related applications. These businesses are developing microscopy systems with enhanced imaging, automation features, and data analysis algorithms that suit the emerging needs of pharmaceutical and biotechnology scientists in drug development and cellular analysis experiments.

Key Questions Answered in This Report

  • 1.How big is the high content screening market?
  • 2.What is the future outlook of high content screening market?
  • 3.What are the key factors driving the high content screening market?
  • 4.Which region accounts for the largest high content screening market share?
  • 5.Which are the leading companies in the global high content screening market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global High Content Screening Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Cell Imaging and Analysis Systems
      • 6.1.2.2 Flow Cytometers
    • 6.1.3 Market Forecast
  • 6.2 Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Major Types
      • 6.2.2.1 Reagents & Assay Kits
      • 6.2.2.2 Microplates
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast
  • 6.3 Software
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Services
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Accessories
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Target Identification and Validation
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Primary Screening and Secondary Screening
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Toxicity Studies
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Compound Profiling
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Pharmaceutical and Biotechnology Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Academic and Government Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Contract Research Organizations (CROs)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Becton, Dickinson and Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Bio-Rad Laboratories Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Biotek Instruments Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Danaher Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 GE Healthcare
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Merck Millipore
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Perkinelmer Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Tecan Group Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Thermo Fisher Scientific
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Yokogawa Electric Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: High Content Screening Market: Major Drivers and Challenges
  • Figure 2: Global: High Content Screening Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: High Content Screening Market: Breakup by Product (in %), 2024
  • Figure 4: Global: High Content Screening Market: Breakup by Application (in %), 2024
  • Figure 5: Global: High Content Screening Market: Breakup by End-User (in %), 2024
  • Figure 6: Global: High Content Screening Market: Breakup by Region (in %), 2024
  • Figure 7: Global: High Content Screening Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 8: Global: High Content Screening (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: High Content Screening (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: High Content Screening (Consumables) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: High Content Screening (Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: High Content Screening (Software) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: High Content Screening (Software) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: High Content Screening (Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: High Content Screening (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: High Content Screening (Accessories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: High Content Screening (Accessories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: High Content Screening (Target Identification and Validation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: High Content Screening (Target Identification and Validation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: High Content Screening (Primary Screening and Secondary Screening) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: High Content Screening (Primary Screening and Secondary Screening) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: High Content Screening (Toxicity Studies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: High Content Screening (Toxicity Studies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: High Content Screening (Compound Profiling) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: High Content Screening (Compound Profiling) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: High Content Screening (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: High Content Screening (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: High Content Screening (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: High Content Screening (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: High Content Screening (Academic and Government Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: High Content Screening (Academic and Government Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: High Content Screening (Contract Research Organizations-CROs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: High Content Screening (Contract Research Organizations-CROs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: North America: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: North America: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: United States: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: United States: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Canada: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Canada: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Asia Pacific: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Asia Pacific: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: China: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: China: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Japan: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Japan: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: India: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: India: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: South Korea: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: South Korea: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Australia: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Australia: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Indonesia: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Indonesia: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Others: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Others: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Europe: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Europe: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Germany: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Germany: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: France: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: France: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: United Kingdom: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: United Kingdom: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Italy: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Italy: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Spain: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Spain: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Russia: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Russia: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Latin America: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Latin America: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Brazil: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Brazil: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Mexico: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Mexico: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Others: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Others: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Middle East and Africa: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Middle East and Africa: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Global: High Content Screening Industry: SWOT Analysis
  • Figure 83: Global: High Content Screening Industry: Value Chain Analysis
  • Figure 84: Global: High Content Screening Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: High Content Screening Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: High Content Screening Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: High Content Screening Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: High Content Screening Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 5: Global: High Content Screening Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: High Content Screening Market: Competitive Structure
  • Table 7: Global: High Content Screening Market: Key Players